First Bancorp, Inc Eli Lilly & CO Transaction History

First Bancorp, Inc

$153 Million
Q1 2025

A detailed history of First Bancorp, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, First Bancorp, Inc holds 492 shares of LLY stock, worth $362,933. This represents 0.27% of its overall portfolio holdings.

Number of Shares

492

Previous 509 3.34%

Holding current value

$362,933

Previous $392,000 3.57%

% of portfolio

0.27%

Previous 0.27%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	SELL	$725.72 - $929.72 $12,337 - $15,805	-17 Reduced 3.34%	492 $406,000
Q4 2024 Jan 21, 2025	SELL	$727.2 - $932.06 $2,908 - $3,728	-4 Reduced 0.78%	509 $392,000
Q3 2024 Oct 18, 2024	SELL	$772.14 - $960.02 $6,177 - $7,680	-8 Reduced 1.54%	513 $454,000
Q2 2024 Jul 23, 2024	SELL	$724.87 - $909.04 $61,613 - $77,268	-85 Reduced 14.03%	521 $471,000
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $61,588 - $82,397	-104 Reduced 14.65%	606 $471,000
Q4 2023 Jan 23, 2024	SELL	$525.19 - $619.13 $15,755 - $18,573	-30 Reduced 4.05%	710 $413,000
Q3 2023 Oct 23, 2023	SELL	$434.7 - $599.3 $19,996 - $27,567	-46 Reduced 5.85%	740 $397,000
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $8,067 - $10,786	-23 Reduced 2.84%	786 $368,000
Q4 2022 Feb 01, 2023	SELL	$321.55 - $374.67 $12,862 - $14,986	-40 Reduced 4.71%	809 $295,000
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $18,974 - $21,623	-64 Reduced 7.01%	849 $274,000
Q2 2022 Jul 14, 2022	SELL	$278.73 - $327.27 $24,806 - $29,127	-89 Reduced 8.88%	913 $296,000
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $64,305 - $79,914	-274 Reduced 21.47%	1,002 $287,000
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $209,672 - $271,430	1,276 New	1,276 $239,000

Others Institutions Holding LLY

# of Institutions

4,388

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $701B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bancorp, Inc , based on Form 13F filings with the SEC.

News

Stay updated on First Bancorp, Inc with notifications on news.

Account

First Bancorp, Inc Eli Lilly & CO Transaction History